Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of ALK Tyrosine Kinase Inhibitors (ALK-TKIs)market, defines the market attractiveness level of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) industry, describes the types of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market, the applications of major players and the market size, and deeply analyzes the current situation of the global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market and the development prospects and opportunities of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market in Chapter 13.
By Player:
Takeda
Betta Pharma
Pfizer
Shouyao Holding
Chugai Pharmaceutical Co
Nuvartis
By Type:
Crizotinib
Alectinib
Ceritinib
Brigatinib
Lorlatinib
Ensartinib
CT-707
By End-User:
Leukemia
Solid Tumor
Lung Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Analysis and Outlook to 2022
-
7.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption (2017-2022)
-
7.2 United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption (2017-2022)
-
7.3 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption (2017-2022)
-
7.4 China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption (2017-2022)
-
7.5 Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption (2017-2022)
-
7.6 India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption (2017-2022)
-
7.7 South Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption (2017-2022)
8 Region and Country-wise ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Analysis and Outlook to 2028
-
8.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast (2022-2028)
-
8.2 United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast (2022-2028)
-
8.3 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast (2022-2028)
-
8.4 China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast (2022-2028)
-
8.5 Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast (2022-2028)
-
8.6 India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast (2022-2028)
-
8.7 South Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast (2022-2028)
9 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Outlook by Types and Applications to 2022
-
9.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Crizotinib Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Alectinib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Ceritinib Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Brigatinib Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Lorlatinib Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Ensartinib Consumption and Growth Rate (2017-2022)
-
9.1.7 Global CT-707 Consumption and Growth Rate (2017-2022)
-
9.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Leukemia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Solid Tumor Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Outlook by Types and Applications to 2028
-
10.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Crizotinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Alectinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Ceritinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Brigatinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Lorlatinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Ensartinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global CT-707 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Import and Export Analysis (Top 5 Countries)
-
11.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Competitive Analysis
-
14.1 Takeda
-
14.1.1 Takeda Company Details
-
14.1.2 Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
14.2 Betta Pharma
-
14.2.1 Betta Pharma Company Details
-
14.2.2 Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
14.4 Shouyao Holding
-
14.4.1 Shouyao Holding Company Details
-
14.4.2 Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
14.5 Chugai Pharmaceutical Co
-
14.5.1 Chugai Pharmaceutical Co Company Details
-
14.5.2 Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
14.6 Nuvartis
-
14.6.1 Nuvartis Company Details
-
14.6.2 Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of ALK Tyrosine Kinase Inhibitors (ALK-TKIs)
-
Figure ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Picture
-
Table Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption by Country (2017-2022)
-
Figure United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption and Growth Rate (2017-2022)
-
Table Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption and Growth Rate (2017-2022)
-
Figure China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption and Growth Rate (2017-2022)
-
Figure Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption and Growth Rate (2017-2022)
-
Figure India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption and Growth Rate (2017-2022)
-
Figure South Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption and Growth Rate (2017-2022)
-
Figure Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast by Country (2022-2028)
-
Figure United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Crizotinib Consumption and Growth Rate (2017-2022)
-
Figure Global Alectinib Consumption and Growth Rate (2017-2022)
-
Figure Global Ceritinib Consumption and Growth Rate (2017-2022)
-
Figure Global Brigatinib Consumption and Growth Rate (2017-2022)
-
Figure Global Lorlatinib Consumption and Growth Rate (2017-2022)
-
Figure Global Ensartinib Consumption and Growth Rate (2017-2022)
-
Figure Global CT-707 Consumption and Growth Rate (2017-2022)
-
Figure Global Leukemia Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Crizotinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alectinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ceritinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brigatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lorlatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ensartinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CT-707 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Import by Region (Top 5 Countries) (2017-2028)
-
Table Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
Table Betta Pharma (Foundation Year, Company Profile and etc.)
-
Table Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
Table Shouyao Holding (Foundation Year, Company Profile and etc.)
-
Table Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
Table Chugai Pharmaceutical Co (Foundation Year, Company Profile and etc.)
-
Table Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
Table Nuvartis (Foundation Year, Company Profile and etc.)
-
Table Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product and Service
-
